EX-23.1 8 labp-ex23_1.htm EX-23.1 EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-256185) pertaining to the 2019 Equity Incentive Plan and 2021 Employee Stock Purchase Plan of Landos Biopharma, Inc. of our report dated March 24, 2022, with respect to the consolidated financial statements of Landos Biopharma, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2021.

 

/s/ Ernst & Young LLP

Raleigh, NC

March 24, 2022